These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36195478)
1. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor? Tachibana I; Kern SQ; Douglawi A; Tong Y; Mahmoud M; Masterson TA; Adra N; Foster RS; Einhorn LH; Cary C Eur Urol; 2023 Jan; 83(1):e20-e21. PubMed ID: 36195478 [No Abstract] [Full Text] [Related]
2. Re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor? Ghoreifi A; Djaladat H Eur Urol; 2023 Jan; 83(1):e18-e19. PubMed ID: 36195480 [No Abstract] [Full Text] [Related]
3. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.033. Liedberg F; Kollberg P; Allerbo M; Baseckas G; Brändstedt J; Gudjonsson S; Hagberg O; Håkansson U; Jerlström T; Löfgren A; Patschan O; Sörenby A; Bläckberg M Eur Urol; 2020 Nov; 78(5):e186-e187. PubMed ID: 32950295 [No Abstract] [Full Text] [Related]
4. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors. Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792 [TBL] [Abstract][Full Text] [Related]
5. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. Wood DP; Herr HW; Heller G; Vlamis V; Sogani PC; Motzer RJ; Fair WR; Bosl GJ J Urol; 1992 Dec; 148(6):1812-5; discussion 1815-6. PubMed ID: 1331547 [TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant chemotherapy in patients with stage II nonseminomatous germ-cell tumors. Motzer RJ; Bosl GJ Urol Clin North Am; 1993 Feb; 20(1):111-6. PubMed ID: 8381992 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review. Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080 [TBL] [Abstract][Full Text] [Related]
8. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience. Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors]. Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998 [TBL] [Abstract][Full Text] [Related]
10. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options. Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590 [TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle. Yoon GH; Stein JP; Skinner DG Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440 [TBL] [Abstract][Full Text] [Related]
12. National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy. Labbate CV; Werntz RP; Galansky LB; Packiam VT; Eggener SE Urol Oncol; 2020 Aug; 38(8):687.e13-687.e18. PubMed ID: 32305267 [TBL] [Abstract][Full Text] [Related]
13. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers? Powles T Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606 [TBL] [Abstract][Full Text] [Related]
14. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study. Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center. Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782 [TBL] [Abstract][Full Text] [Related]
16. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998 [TBL] [Abstract][Full Text] [Related]
17. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis]. Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511 [No Abstract] [Full Text] [Related]
18. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383 [TBL] [Abstract][Full Text] [Related]
19. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M; J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040 [TBL] [Abstract][Full Text] [Related]